-
1Academic Journal
المؤلفون: Cruijsen, M, van der Velden, W J F M, de Haan, A F J, Klein, S K, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, L F, Vellenga, E, Blijlevens, N, van de Loosdrecht, A A, Huls, G
المصدر: Cruijsen , M , van der Velden , W J F M , de Haan , A F J , Klein , S K , Hoogendoorn , M , Tromp , Y , de Valk , B , van Rees , B , de Boer , F , van der Spek , E , Pruijt , J , Verdonck , L F , Vellenga , E , Blijlevens , N , van de Loosdrecht , A A & Huls , G 2020 , ' Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands ....
مصطلحات موضوعية: RISK MYELODYSPLASTIC SYNDROMES, CANCER, MDS
وصف الملف: application/pdf
الاتاحة: https://hdl.handle.net/11370/6f589496-7d1d-40a0-a479-356e1e47405c
https://research.rug.nl/en/publications/6f589496-7d1d-40a0-a479-356e1e47405c
https://doi.org/10.1080/10428194.2020.1775217
https://pure.rug.nl/ws/files/132001396/Use_of_azacitidine_and_its_safety_and_efficacy_in_daily_clinical_practice_in_The_Netherlands_the_OCEAN_study.pdf -
2Electronic Resource
المؤلفون: Cruijsen, M.J., Velden, W.J.F.M. van der, Haan, A.F.J. de, Klein, S.K., Hoogendoorn, M., Tromp, Y., Valk, B. de, Rees, B. van, Boer, F. de, Spek, E. van der, Pruijt, J., Verdonck, L.F., Vellenga, E., Blijlevens, N.M.A., Loosdrecht, A.A. van de, Huls, G.
المصدر: Leukemia & Lymphoma; 2752; 2755; 1042-8194; 11; 61; ~Leukemia & Lymphoma~2752~2755~~~1042-8194~11~61~~
-
3Academic Journal
المؤلفون: Cruijsen, M., van der Velden, W.J.F.M, de Haan, A.F.J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L.F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A., Huls, G.
المصدر: Leukemia & Lymphoma; Nov2020, Vol. 61 Issue 11, p2752-2755, 4p
مصطلحات موضوعية: PATIENT compliance, BLOOD transfusion reaction